Cargando…
JMJD6 promotes melanoma carcinogenesis through regulation of the alternative splicing of PAK1, a key MAPK signaling component
BACKGROUND: Melanoma, originated from melanocytes located on the basal membrane of the epithelial tissue, is the most aggressive form of skin cancer that accounts for 75% of skin cancer-related death. Although it is believed that BRAF mutation and the mitogen-activated protein kinase (MAPK) pathway...
Autores principales: | Liu, Xujun, Si, Wenzhe, Liu, Xinhua, He, Lin, Ren, Jie, Yang, Ziran, Yang, Jianguo, Li, Wanjin, Liu, Shumeng, Pei, Fei, Yang, Xiaohan, Sun, Luyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5708181/ https://www.ncbi.nlm.nih.gov/pubmed/29187213 http://dx.doi.org/10.1186/s12943-017-0744-2 |
Ejemplares similares
-
JMJD6 Promotes Colon Carcinogenesis through Negative Regulation of p53 by Hydroxylation
por: Wang, Feng, et al.
Publicado: (2014) -
ZNF516 suppresses EGFR by targeting the CtBP/LSD1/CoREST complex to chromatin
por: Li, Lifang, et al.
Publicado: (2017) -
PAK Signaling Drives Acquired Drug Resistance to MAPK Inhibitors in BRAF-mutant Melanomas
por: Lu, Hezhe, et al.
Publicado: (2017) -
JMJD4-demethylated RIG-I prevents hepatic steatosis and carcinogenesis
por: Li, Zhenyang, et al.
Publicado: (2022) -
JMJD6 and U2AF65 co-regulate alternative splicing in both JMJD6 enzymatic activity dependent and independent manner
por: Yi, Jia, et al.
Publicado: (2017)